Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi Winthrop Industrie Gentilly FR
02 1Archimica Ltd Nr. Chester GB
01 2Carbasalate calcium
01 1France
02 1United Kingdom
01 1Valid
02 1Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 2000-148 - Rev 03
Status : Valid
Issue Date : 2010-05-19
Type : Chemical
Substance Number : 1185
Certificate Number : R0-CEP 2003-106 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2006-08-30
Type : Chemical
Substance Number : 1185
76
PharmaCompass offers a list of Carbaspirin Calcium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carbaspirin Calcium manufacturer or Carbaspirin Calcium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carbaspirin Calcium manufacturer or Carbaspirin Calcium supplier.
PharmaCompass also assists you with knowing the Carbaspirin Calcium API Price utilized in the formulation of products. Carbaspirin Calcium API Price is not always fixed or binding as the Carbaspirin Calcium Price is obtained through a variety of data sources. The Carbaspirin Calcium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carbasalatum calcicum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbasalatum calcicum, including repackagers and relabelers. The FDA regulates Carbasalatum calcicum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbasalatum calcicum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carbasalatum calcicum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carbasalatum calcicum supplier is an individual or a company that provides Carbasalatum calcicum active pharmaceutical ingredient (API) or Carbasalatum calcicum finished formulations upon request. The Carbasalatum calcicum suppliers may include Carbasalatum calcicum API manufacturers, exporters, distributors and traders.
click here to find a list of Carbasalatum calcicum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carbasalatum calcicum CEP of the European Pharmacopoeia monograph is often referred to as a Carbasalatum calcicum Certificate of Suitability (COS). The purpose of a Carbasalatum calcicum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbasalatum calcicum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbasalatum calcicum to their clients by showing that a Carbasalatum calcicum CEP has been issued for it. The manufacturer submits a Carbasalatum calcicum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbasalatum calcicum CEP holder for the record. Additionally, the data presented in the Carbasalatum calcicum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbasalatum calcicum DMF.
A Carbasalatum calcicum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbasalatum calcicum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbasalatum calcicum suppliers with CEP (COS) on PharmaCompass.
